Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Vickers
    Vickers
  3. Russo
    Russo
  4. Eastham
    Eastham
  5. Jarnagin
    Jarnagin
  6. Reuter
    Reuter
  7. D'Angelica
    D'Angelica
  8. Kingham
    Kingham
  9. Ladanyi
    Ladanyi
  10. Scher
    Scher

Groups

  1. Surgery (2049)
  2. Department of Medicine (1334)
  3. Urology (1158)
  4. Solid Tumor Oncology Division (829)
  5. Population Sciences Research Program (816)
  6. Survivorship Research (716)
  7. Epidemiology and Biostatistics (685)
  8. Sloan Kettering Institute Faculty (612)
  9. Department of Pathology and Laboratory Medicine (586)
  10. GSK Faculty (582)
Search Within
Formats
  1. Journal Article (3901)
  2. Meeting Abstract (1049)
  3. Editorial (165)
  4. Review (132)
  5. Correspondence (113)
  6. Guidelines (79)
  7. Research Letter (29)
  8. Conference Paper (27)
  9. Book Section (5)
  10. Miscellaneous (3)
Groups
  1. Surgery (2049)
  2. Department of Medicine (1334)
  3. Urology (1158)
  4. Solid Tumor Oncology Division (829)
  5. Population Sciences Research Program (816)
  6. Survivorship Research (716)

More Groups

People
  1. Harry Herr (270)
  2. Andrew Vickers (223)
  3. Paul Russo (185)
  4. Peter Scardino (173)
  5. James Eastham (161)
  6. William Jarnagin (157)

More People

Years
  1. 2025 (96)
  2. 2024 (256)
  3. 2023 (234)
  4. 2022 (264)
  5. 2021 (233)
  6. 2020 (264)

More Years

Publications
  1. Journal of Urology (762)
  2. European Urology (570)
  3. Lancet Oncology (394)
  4. Urology (388)
  5. Journal of the American College of Surgeons (346)
  6. Journal of Molecular Diagnostics (272)

More Publications

Results (5503)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ANRIL inherited variants associated with primary melanoma TIL grade
    Meeting Abstract

    Davari, D. R.; Orlow, I.; Kanetsky, P. A.; Luo, L.; Busam, K. J.; Cust, A. E.; Begg, C. B.; Berwick, M.; Thomas, N. E.
    Journal of Investigative Dermatology (2021)

    Fulltext@MSK | Save
  • Rational engineering of recombinant modified vaccinia virus Ankara to enhance both innate and adaptive immunity for cancer immunotherapy
    Meeting Abstract

    Yang, N.; Wang, Y.; Liu, S.; Luna, J.; Rossi, A.; Mazo, G.; Tan, A.; Wang, J.; Yan, W.; Choi, J.; more...
    Journal of Investigative Dermatology (2021)

    Fulltext@MSK | Save
  • Acceptable delay between diagnosis and treatment of melanoma, cutaneous squamous cell carcinoma, and basal cell carcinoma
    Meeting Abstract

    Alam, M.; Etzkorn, J.; Albertini, J. G.; Bordeaux, J.; Council, L.; Maher, J. A.; Nehal, K. S.; Brodland, D. G.; Haas, A. F.; Ibrahim, S. A.; more...
    Journal of Investigative Dermatology (2021)

    Fulltext@MSK | Save
  • Utilizing in vivo proximity labeling combined with affinity purification-mass spectrometry to investigate interacting partners of vaccinia dsRNA-binding protein E3
    Meeting Abstract

    Mazo, G.; Hendrickson, R.; Deng, L.
    Journal of Investigative Dermatology (2021)

    Fulltext@MSK | Save
  • Ovarian-adnexal reporting lexicon for MRI: A white paper of the ACR Ovarian-Adnexal Reporting and Data Systems MRI Committee
    Journal Article

    Reinhold, C.; Rockall, A.; Sadowski, E. A.; Siegelman, E. S.; Maturen, K. E.; Vargas, H. A.; Forstner, R.; Glanc, P.; Andreotti, R. F.; Thomassin-Naggara, I.
    Journal of the American College of Radiology (2021)

    Fulltext@MSK | Save
  • ACR–ABS–ACNM–ASTRO–SIR–SNMMI practice parameter for selective internal radiation therapy or radioembolization for treatment of liver malignancies
    Guidelines

    Hong, K.; Akinwande, O.; Bodei, L.; Chamarthy, M. R.; Devlin, P. M.; Elman, S.; Ganguli, S.; Kennedy, A. S.; Koo, S. J.; Ouhib, Z.; more...
    Brachytherapy (2021)

    Fulltext@MSK | Save
  • Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): A double-blind, randomised, placebo-controlled, phase 3 trial
    Journal Article

    Matasar, M. J.; Capra, M.; Özcan, M.; Lv, F.; Li, W.; Yañez, E.; Sapunarova, K.; Lin, T.; Jin, J.; Jurczak, W.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): A randomised, phase 3 trial
    Journal Article

    Friedlander, M.; Moore, K. N.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Lisyanskaya, A.; Sonke, G. S.; Gourley, C.; Banerjee, S.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Breast cancer
    Review

    Loibl, S.; Poortmans, P.; Morrow, M.; Denkert, C.; Curigliano, G.
    Lancet (2021)

    Fulltext@MSK | Save
  • Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): An open-label, randomised, phase 3 trial
    Journal Article

    Andre, T.; Amonkar, M.; Norquist, J. M.; Shiu, K. K.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C. J. A.; Smith, D.; Garcia-Carbonero, R.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save